Browse by Medical Category
Accepting New Patients
Associate Professor of Psychology (Psychiatry), Harvard Medical School;Co-Director, Trichotillomania Clinic and Research Unit;Chief Psychologist, Obsessive Compulsive Disorder Clinic and Research Unit
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Nancy Keuthen is a graduate of Brown University and the clinical psychology program at Stony Brook University. She completed her internship at the Brockton-West Roxbury Veterans Administration Medical Center. Since 1986 she has been on staff at Massachusetts General Hospital and faculty at Harvard Medical School. Since 2001 she has been associate professor of psychology (psychiatry) at Harvard Medical School. She is the former director of the Cognitive Behavioral Therapy Program at Massachusetts General Hospital.
Dr. Keuthen has been chair, vice-chair and member of the scientific advisory board of the Trichotillomania Learning Center and member of the scientific advisory board of the International Obsessive-Compulsive Disorder Foundation. She has been guest editor for several scientific journals. She is a founding member of the International Trichotillomania Research Consortium.
Dr. Keuthen has made important contributions to the diagnosis, etiology and treatment of obsessive-compulsive disorder as well as the related disorders of trichotillomania, pathological skin picking and body dysmorphic disorder. Her bibliography lists nearly 100 peer-reviewed publications in this field in addition to a book, numerous chapters, educational materials and Internet-based self-help materials.
See PubMed for recent publications.
Keuthen NJ, Koran LM, Aboujaoude E, Large MD, Serpe RT. The Prevalence of Pathological Skin Picking in U.S. Adults. Compr Psych 2010;51: 183-186.
Flessner CA, Penzel F, Trichotillomania Learning Center-Scientific Advisory Board, Keuthen NJ. Current treatment practices for children and adults with trichotillomania. Cog Behav Pract 2010; 17: 290-300.
A new study has identified a potential strategy for removing the abnormal protein that causes Huntington’s disease from brain cells, which could slow the progression of the devastating neurological disorder.
Back to Top